H
Harvest
Tax-loss replacement research
NVO
Novo Nordisk
Health CarePharmaceuticalsPharmaceuticals
30 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for NVO

Among the 30 Pharmaceuticals peers screened, PTCT (PTC Therapeutics, Inc.) has tracked NVO most closely over the past year, with a return correlation of 0.26. The strongest fund stand-in is PPH (VanEck Pharma ETF) at 0.40 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
PTCTPTC Therapeutics, Inc.Pharmaceuticals0.260.110.110.13
PFEPfizer Inc.Pharmaceuticals0.250.190.190.26
AZNAstraZenecaPharmaceuticals0.250.260.300.35
ABBVAbbVie Inc.Pharmaceuticals0.240.210.200.26
VTRSViatrisPharmaceuticals0.230.220.200.21
LLYEli LillyPharmaceuticals0.200.330.380.38
AMPHAmphstar Pharmaceuticals, Inc.Pharmaceuticals0.190.200.180.21
ALKSAlkermes plcPharmaceuticals0.190.130.150.17
ANIPANI Pharmaceuticals, Inc.Pharmaceuticals0.180.190.150.17
ACADAcadia PharmaceuticalsPharmaceuticals0.180.130.130.12
OGNOrganon & Co.Pharmaceuticals0.180.140.18
CORTCorcept Therapeutics IncorporatedPharmaceuticals0.170.100.090.12
AMRXAmneal PharmaceuticalsPharmaceuticals0.170.160.130.14
SUPNSupernus Pharmaceuticals, Inc.Pharmaceuticals0.160.020.070.13
ELANElancoPharmaceuticals0.160.210.200.21
PRGOPerrigoPharmaceuticals0.160.150.170.20
PBHPrestige Consumer HealthcarePharmaceuticals0.140.130.140.17
ZTSZoetis Inc.Pharmaceuticals0.140.190.230.29
SNYSanofi S.A.Pharmaceuticals0.140.210.230.31
GSKGSK plcPharmaceuticals0.130.220.250.31
JAZZJazz PharmaceuticalsPharmaceuticals0.130.160.180.20
BMYBristol-Myers SquibbPharmaceuticals0.130.170.180.23
LQDALiquidia CorporationPharmaceuticals0.110.150.120.12
MRKMerck & Co.Pharmaceuticals0.110.210.220.29
INDVIndiviorPharmaceuticals0.090.090.040.05
COLLCollegium Pharmaceutical, Inc.Pharmaceuticals0.070.160.140.14
PCRXPacira BioSciences, Inc.Pharmaceuticals0.060.070.080.10
JNJJohnson & JohnsonPharmaceuticals0.040.070.120.22
INVAInnoviva, Inc.Pharmaceuticals0.040.120.100.16
PAHCPhibro Animal HealthPharmaceuticals0.030.100.120.15
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.400.500.510.52
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.340.390.400.43
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.340.390.400.43
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.330.340.330.38
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.320.390.400.43
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.310.380.390.43
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.300.320.330.36
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.300.270.250.30
XHESPDR S&P Health Care EquipmentMedical Devices (Equal Wt)SUB-IND0.290.260.260.30
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.280.360.390.41
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.240.230.250.30
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.220.260.280.34
NEXT STEPS

Harvesting a loss in NVO?

RELATED

Replacement research for NVO's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.